A Natural Fungal Supplement Enhances COVID-19 Vaccine Efficacy
A groundbreaking study conducted by researchers at the University of California San Diego School of Medicine has revealed a natural fungal supplement's potential to revolutionize COVID-19 vaccine efficacy. The research, published in BMC Immunology on March 3, 2026, demonstrates that this supplement, derived from the mycelium of two medicinal fungi, significantly reduces short-term vaccine side effects and enhances antibody durability in individuals who have not been previously exposed to the virus.
The study, a randomized, double-blind, placebo-controlled clinical trial, involved 90 adults receiving a COVID-19 vaccine. Participants were randomly assigned to take either the fungal supplement or placebo capsules for four days, starting on the day of vaccination. The results were remarkable, showing that the supplement, named FoTv, was both safe and highly effective.
The strongest benefits were observed in participants who had never had COVID-19 and were not previously vaccinated. These individuals experienced significantly fewer vaccine side effects and demonstrated a continuous increase in antibody levels over the six-month study period. This is particularly noteworthy as antibody levels typically rise, peak, and then gradually decline after vaccination.
Gordon Saxe, MD, PhD, MPH, the study's principal investigator, explained, 'Our goal was to assess whether FoTv, a natural immune regulator, could reduce vaccine side effects while maintaining or enhancing antibody levels and extending vaccine protection. The findings suggest that it achieved both of these objectives.'
The study's implications are far-reaching. By decreasing side effects and improving antibody durability, the supplement may address vaccine hesitancy and potentially reduce the need for frequent booster shots. This is especially crucial as the world grapples with emerging infectious threats, such as the H5N1 avian influenza strain.
Saxe emphasized the potential of this natural approach, stating, 'With the threat of H5N1 avian influenza looming, we require affordable and rapidly scalable tools that can strengthen vaccines without increasing side effects. This study indicates that FoTv, a carefully tested natural immune modulator, may contribute to this goal. Given our evolutionary connection to fungi and the presence of fungal compounds in human immune cells, the potential medical applications of fungi like FoTv are vast and largely unexplored.'
However, Saxe also stressed the need for further research to fully understand the supplement's mechanisms and confirm the study's findings. The study was funded by various organizations, including the University of California San Diego Krupp Endowed Fund and the Jonathan and Kathleen Altman Foundation, ensuring its impartiality and scientific rigor.
The fungal mycelium used in the study was sourced from Fungi Perfecti, LLC, a company specializing in natural fungal products. The authors declare no competing interests, and Saxe was recused from decision-making regarding the grant award to maintain objectivity.
This research offers a promising avenue for enhancing vaccine efficacy and addressing the challenges posed by infectious diseases. As the world continues to battle the COVID-19 pandemic and prepare for future health crises, natural supplements like FoTv may play a pivotal role in strengthening our immune defenses.
